Arsenal Capital Partners completed the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry. Financial terms were not disclosed. "Arsenal is building businesses to tackle some of healthcare's most pressing challenges. Our investment in BresMed is the foundation to a platform that will help pharmaceutical companies substantiate and convey the value of their products — a critical need in drug development. We are delighted to partner with the talented group at BresMed and our executive team in this important endeavor," Gene Gorbach, Arsenal Investment Partner.